Solar Energy News  
EPIDEMICS
Scientists make breakthrough in malaria infection study of humans, apes
by Ashley Williams
Washington DC (UPI) Apr 6, 2021

Scientists have solved a century-long puzzle involving malaria parasite infection in people and chimpanzees, a study released Wednesday reveals.

A report published in the peer-reviewed Nature Communications journal explains the origins of the parasite Plasmodium malariae, or P. malariae.

Before evolving to infect humans, experts have discovered that the P. malariae, one of the least well-understood parasites, originates in African apes.

Scientists from the University of Edinburgh in Scotland and the University of Pennsylvania collaborated on analyzing the parasites' DNA to make the breakthrough finding in the National Institutes of Health-funded study.

Researchers say an infection with P. malariae, one of the six species that spreads malaria among humans, is often mild.

However, untreated, it can cause potentially chronic, lifelong infections.

The mystery dates back to the 1920s, when experts discovered chimps infected with parasites that appeared under microscopes to be identical to P. malariae.

Until now, scientists had assumed that both parasites belonged to the same species.

This couldn't be verified in the past because the chimpanzee strain's genetic makeup hadn't before been studied.

DNA analysis has shown that there are three distinct species. P. malariae is the parasitic protozoan that primarily infects humans, while the other two species infect apes.

Central and West Africa-based chimps, gorillas and bonobos were found to be sources of one of the two ape-infecting parasite species that was previously unknown.

The study found that it is only "distantly related" to the human parasite.

Meanwhile, scientists found that the other ape parasite is a closer match to the one that infects people. This knowledge helped researchers more closely compare the two species' diverse genetic makeups.

According to the University of Edinburgh, this finding revealed that the human malaria parasite population went through a genetic bottleneck, causing a temporary shrinking of its population.

Most of the parasite's genetic variation was lost as a result, the research team found.

Scientists assume this occurred because P. malariae started out as an ape parasite, but a small number of parasites switched hosts and began to infect people.

"Our findings could provide vital clues on how it became able to infect people, as well as helping scientists gauge if further jumps of ape parasites into humans are likely," said Edinburgh's Lindsey Plenderleith, lead researcher of the study.

An estimated 241 million malaria cases and 627,000 malaria deaths were reported worldwide in 2020, according to the World Health Organization.


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Shares soar in Chinese drugmaker after positive Covid drug trials
Beijing (AFP) April 6, 2022
Shares in the Chinese pharmaceutical group Kintor rocketed on Wednesday after it reported that trials had shown its Covid-19 drug to be highly effective, making it potentially China's first homegrown antiviral treatment. Shares closed up more than 100 percent in Hong Kong after the group said its new pill dramatically reduced the risk of hospitalisation or death from Covid-19, particularly among the middle-aged or elderly. The drug, proxalutamide, cut the risk of hospitalisation or deaths by 50 ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
Fuel from waste wood

Breaking down plastic into its constituent parts

Could we make cars out of petroleum residue?

Conversion process turns pollution into cash

EPIDEMICS
Does this artificial intelligence think like a human?

Return of the Battling Robots

Robots dress humans without the full picture

How scientists reviewed the process and development of space intelligent robot technology?

EPIDEMICS
Brazil to hold first offshore wind tender by October: official

Bionic wing flaps improve wind energy efficiency

India to build Sri Lanka wind farms after China pushed aside

Netherlands doubles wind energy targets for 2030

EPIDEMICS
Rome unveils 650 mn euros eco cars boost

Interurban Vehicle - Green and comfortable travel even on long journeys

Uber to integrate its network with New York yellow cabs

Toyota pauses most Japan production after quake

EPIDEMICS
Freeze-thaw battery is adept at preserving its energy

Novel use of iron-laced carbon nanofibers yields high-performance energy storage

Nuclear fusion hit a milestone thanks to better reactor walls

The material that could save industries heat

EPIDEMICS
Toshiba pauses spin-off plan, weighs going private

Hungary gets first delivery of Russia nuclear fuel since war

Safely storing Canada's used nuclear fuel for millennia

UK may build seven nuclear plants by 2050: minister

EPIDEMICS
Compact, green and car-free. Can city living beat climate change?

Lots of low- and no-cost ways to halt global warming

Govts, businesses 'lying' on climate efforts: UN chief

Mexico, US talks fail to end energy reform frictions

EPIDEMICS
Kenyans heal devastated land with the power of mangroves

US trees may provide over $100 billion dollars in savings via environmental benefits

How deforestation is triggering an irreversible transition in amazon forests?

Indigenous lands key to climate goals in Latin America: report









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.